Abstract
Background:Rheumatoid arthritis (RA) treatment has now many variations with use of biologic or targeted synthetic disease modifying anti-rheumatic drugs (b/tsDMARDs) and conventional synthetic disease modifying anti-rheumatic drugs (csDMARDs). In these,...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
